Nasdaq Biotechnology Ishares ETF (IBB)
$156.93
0.22 (0.14%)
19:21 EST
IBB Stock Quote Delayed 30 Minutes
Previous Close
-
Market Cap
13.65B
PE Ratio
-
EPS
-
Volume (Avg. Vol.)
4.56M
Day's Range
154.13 - 159.17
52-Week Range
92.15 - 174.04
Dividend & Yield
0.31 (0.20%)
IBB Stock Predictions, Articles, and Nasdaq Biotechnology Ishares ETF News
- From InvestorPlace
- From the Web
3 Biotech Stocks to Buy As Things Heat Up for the Sector
Biotech stocks offer a textbook retracement pattern. The risk is low, and the reward is high. Here's how to play it.
Which Biotech Stocks Are a Buy on Earnings?
If you’re interested in high-growth biotech stocks with superior fundamentals, here are which ones to consider, and which ones to skip.
3 Biotech Stocks to Buy Right Now
Regardless of lockdowns or otherwise, these biotech stocks are positioned to rally strongly in the weeks and months ahead
4 Biotech Stocks to Buy for Big Gains in 2020
The novel coronavirus is weighing on the market, but these four biotech stocks can survive. Here's what you need to know to profit now.
A New Healthcare Stock Pick in the Industry of the Decade
This company is riding a powerful trend in the future of healthcare. Plus, it offers high growth, a huge potential market and a path to profitability.
The 5 Best Tech ETFs to Buy for Safer Growth
Here are five tech ETFs to buy if you believe that global technology stocks will continue to enjoy their solid runs in the coming quarters.
3 Biotech Stock ETFs to Buy For Further Upside In 2021
Biotech stocks are winners this year, but there's still room to buy in for profit taking. ETFs such as IBB, XBI and XLV will continue to win.
Biotech Stocks Have Been on Fire, But Timing Is Everything
Consensus is that the experts will find a vaccine to Covid-19 soon, so the biotech stocks have rallied hard. Buying them now carries risk.
Biotech Stocks: Coronavirus Response Shows How Far We’ve Come …
Look for biotech stocks as a group to gain more than 20% this year … with the best, most innovative firms more than doubling.
3 Healthcare Stocks to Buy This Year
The buyers are in charge of the healthcare stocks this year. And judging from their charts, these stocks and ETFs in particular offer great opportunities.
First-Mover Advantage Will Benefit Amarin Stock More Than You Think
By
Ian Cooper
There’s no reason Amarin stock won’t become a big success with Vascepa, especially with access to millions of patients.
The Top Performing Sector in 2020 Will Be …
The future of healthcare will really start to take shape this year, and the next decade will bring advancements that we can only imagine in our wildest dreams.
3 Top Drug Stocks to Own In 2020
By
Ian Cooper
Some of the biggest catalysts for future growth in drug stocks include the millions of retiring baby boomers, and new innovative treatments for a variety of medical issues.
3 of the Best Biotech ETFs on the Market
The fourth quarter has been a different story. IBB, the largest biotech ETF by assets, is up 16.65% since Oct. 1, pushing its year-to-date gain to 26.57% as of Dec. 20. That after months of investors pulling money from actively managed biotech funds, but that situation is starting to correct as well as data out this month indicate investors are warming to biotech assets again.
Why We Had to Add This Stock to Our 2020 “Screaming Buy” List
Our research and analysis have identified another name in biotech stocks with big potential in 2020.
You Can’t Afford to Miss This Buying Opportunity
There's a catalyst on the horizon that could send biotech stocks soaring into the stratosphere.
Use Aimmune Therapeutics to Profit off the Rush Into Biotech
By
Ken Trester
This morning, I'm recommending a bullish call option on Aimmune Therapeutics, Inc. (NASDAQ:AIMT), the biopharmaceutical company.
4 Top Stock Trades for Friday: MU, Biotech, Bitcoin
Bitcoin, Biotech, Micron and Starbucks were our top stock trades to watch. Here's how the charts are setting up going into Friday.
8 Biotech Stocks to Watch After the Q2 Earnings Season
Uncertainty is a constant risks for biotech stocks. Which ones matter? Some are down so much investors cannot ignore them now.
7 Biotech ETFs That Should Remain Healthy
The healthcare sector has been the worst performing on the S&P 500 in 2019, but these biotech ETFs are still worth a look.
The Week Ahead In Biotech (Feb. 28-March 6): KemPharm, Gilead FDA Decisions and More Earnings
From
Benzinga